Speaker(s): 

Juliann Savatt, MS, CGC, Staff Member, Geisinger - has nothing to disclose.
Alyson Floyd, MC, CGC, Staff Member, Geisinger - has nothing to disclose.

Learning Objectives: 

  • Describe existing and new efforts to support providers and patients during genomic result return and in completing recommended care.
  • Summarize recent process changes and quality improvements within MyCode Genomic Screening and Counseling (GSC) program including expansion of disclosure to next of kin of deceased participant and transition of disclosure responsibilities to genetic counseling assistants.
  • Review genes recently added to the MyCode gene list, including rationale for inclusion and impacts on care.

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Stefanie Leader, DO, Stanley Martin, MD, Dan Dometita, DO, Malachi Courtney, MD, Eric Hossler, DO, Stacey Coolbaugh, RDN, and Donald Weider, PA-C have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 
 
Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None

Session date: 
05/01/2026 - 12:00pm to 1:00pm EDT
Location: 
Virtual via Microsoft Teams
Danville, PA 17822
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AAPA Category I CME
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 CDR
  • 1.00 Participation Credit
Please login or register to take this course.